AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Sunshine Biopharma Inc.
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SVBT66
0.15▼ 0.02 (-10.18%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.17
Day's Range
0.13 – 0.17
52-Week Range
0.13 – 3.05
Volume
2.1M
Avg Volume
10.7M
Share Statistics
Shares Outstanding
Employees
50
Exchange
XNAS
Listed
2007-08-09
Share count as of August 13, 2026

Sunshine Biopharma Inc. (SBFM) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Sunshine Biopharma Inc. (SBFM)
What is Sunshine Biopharma Inc.'s Market Cap?
Sunshine Biopharma Inc.'s Market Cap is $581.6K, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Enterprise Value?
Sunshine Biopharma Inc.'s Enterprise Value is -$13.2M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Price / Sales?
Sunshine Biopharma Inc.'s Price / Sales is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s EV / Revenue?
Sunshine Biopharma Inc.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s EV / EBITDA?
Sunshine Biopharma Inc.'s EV / EBITDA is 2.4×, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Revenue (TTM)?
Sunshine Biopharma Inc.'s Revenue (TTM) is $35.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Net Income (TTM)?
Sunshine Biopharma Inc.'s Net Income (TTM) is -$5.8M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s EBITDA?
Sunshine Biopharma Inc.'s EBITDA is -$5.5M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Diluted EPS (TTM)?
Sunshine Biopharma Inc.'s Diluted EPS (TTM) is -1.50, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s EBITDA Margin?
Sunshine Biopharma Inc.'s EBITDA Margin is -15.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SBFMAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-1.6%-9.1%-10.6%+11.6%
Cost of Revenue
Gross profit
% of revenue26.2%27.0%35.3%32.6%
General & Administrative Expenses:
Professional Fees
Total Operating Expenses
Non-Operating Income (Expense)
Marketing Expense
Selling, General and Administrative Expense
Research and Development Expense
Labor and Employee Benefits
Amortization of Intangibles———
Depreciation Expense
Total General & Administrative Expenses
(Loss) from operations
% of revenue-17.4%-17.3%-20.9%-11.5%
Other Income (Expense):
Foreign Currency Gain/Loss
Non-Operating Income (Expense)———
Total Other Income
Net (loss) before income taxes
Provision for income taxes
Net (Loss)
% of revenue-16.9%-15.4%-25.0%-9.4%
Other comprehensive income:
Gain (Loss) from foreign exchange translation
Comprehensive (Loss)
Earnings Per Share (Basic)